Primary adherence to controller medications for asthma is poor

Annals of the American Thoracic Society

Volumn 12, Issue 2, 2015, Pages 161-166

  Wu, Ann Chen ^a,b,c   Butler, Melissa G ^d   Li, Lingling ^a   Fung, Vicki ^c   Kharbanda, Elyse O ^e   Larkin, Emma K ^f   Vollmer, William M ^g   Miroshnik, Irina ^a   Davis, Robert L ^h   Lieu, Tracy A ^a,b,c,i   Soumerai, Stephen B ^a  

^a HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^b Children's Hospital   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KAISER PERMANENTE   (United States)

^e HEALTHPARTNERS INSTITUTE   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CENTER FOR HEALTH RESEARCH   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁱ DIVISION OF RESEARCH   (United States)

Author keywords

Adherence; Asthma; Inhaled corticosteroids; Leukotriene antagonists; Medications

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID; CORTICOSTEROID LONG ACTING BETA AGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT DURATION; AFRICAN AMERICAN; CHILD; HISPANIC; INFANT; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AFRICAN AMERICANS; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; INFANT; INFANT, NEWBORN; LEUKOTRIENE ANTAGONISTS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84926452839     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201410-459OC     Document Type: Article

References (27)

1. National Heart, Lung, and Blood Institute: Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health; 2012.
2. Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 2007;120:1043-1050.
3. Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, et al.; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72.
4. Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005;116:360-369.
5. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev [serial on the Internet]. 2012 [accessed January 2015]; 5: CD002314. Available from: http://summaries.cochrane.org
6. National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health; 2007.
7. American Lung Association. Trends in asthma morbidity and mortality. Washington, DC: American Lung Association; 2012.
8. Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M: Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011;128:1185-1191.e2.
9. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195, 930 electronic prescriptions. J Gen Intern Med 2010;25:284-290.
10. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, Rand CS, Apter AJ, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol 2007;120:1153-1159.
11. Apter AJ, Boston RC, George M, Norfleet AL, Tenhave T, Coyne JC, Birck K, Reisine ST, Cucchiara AJ, Feldman HI. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white. J Allergy Clin Immunol 2003;111:1219-1226.
12. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-1057.
13. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-884.
14. Stern L, Berman J, Lumry W, Katz L, Wang L, Rosenblatt L, Doyle JJ. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol 2006;97:402-408.
15. Lasmar L, Camargos P, Champs NS, Fonseca MT, Fontes MJ, Ibiapina C, Alvim C, Moura JA. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 2009;64:784-789.
16. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-461.
17. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-1293.
18. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-864.
19. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
20. Wu AC, Smith L, Bokhour B, Hohman KH, Lieu TA. Racial/ethnic variation in parent perceptions of asthma. Ambul Pediatr 2008;8:89-97.
21. Liberman JN, Hutchins DS, Popiel RG, Patel MH, Jan SA, Berger JE. Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. Am J Pharm Benefits 2010;2:111-118.
22. Tran N, Coffman JM, Sumino K, Cabana MD. Patient reminder systems and asthma medication adherence: a systematic review. J Asthma 2014;51:536-543.
23. Friedman HS, Navaratnam P, McLaughlin J. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma 2010;47:994-1000.
24. Blais L, Kettani FZ, Beauchesne MF, Lemière C, Perreault S, Forget A. New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy. Ann Pharmacother 2011;45:335-341.
25. Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001;17:96-104.
26. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 2001;21:1464-1467.
27. Perrin K, Williams M, Wijesinghe M, James K, Weatherall M, Beasley R. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting b-agonist inhaler therapy in asthma. J Allergy Clin Immunol 2010;126:505-510.